UiPath, Inc. (NYSE:PATH) Stock Has Average Price Target of $16.06 According to Analysts

Shares of UiPath, Inc. (NYSE:PATH – Get Free Report) have earned an average rating of “Hold” from the twenty-one research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $16.06.

PATH has been the topic of several recent analyst reports. Morgan Stanley cut their target price on UiPath from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Friday, May 29th. Needham & Company LLC reissued a “buy” rating and issued a $22.00 price target on shares of UiPath in a research note on Wednesday. Barclays raised their price target on UiPath from $14.00 to $17.00 and gave the company an “equal weight” rating in a report on Friday, September 4th. Bank of America lifted their price objective on shares of UiPath from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, September 4th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of UiPath in a report on Wednesday.

Check Out Our Latest Report on UiPath

More UiPath News

Here are the key news stories impacting UiPath this week:

  • Positive Sentiment: UiPath customer adoption is demonstrating real-world demand for agentic automation, with one customer reportedly processing approximately 100,000 medical billing cases per week. This supports the company’s case that its technology can deliver measurable productivity gains at enterprise scale. Accountable intelligence – how a UiPath customer is using agentic automation to process 100,000 medical billing cases a week
  • Positive Sentiment: The company introduced Cartographer and additional workflow automation and software-testing capabilities intended to connect business processes, software agents and enterprise AI orchestration. These tools could expand UiPath’s addressable market if they accelerate customer adoption. UiPath’s new tool could unlock a much bigger wave of automated business processes
  • Positive Sentiment: UiPath announced the 2026 GeekWire AI Breakthrough Award winners, showcasing enterprises using agentic AI in production. The recognition may improve market visibility and reinforce the company’s positioning in enterprise AI. UiPath Announces Winners of the 2026 Geekwire AI Breakthrough Awards
  • Neutral Sentiment: Needham reaffirmed its Buy rating, while Barclays and TD Cowen maintained Hold ratings, indicating mixed Wall Street conviction rather than a clear consensus. Needham reaffirms Buy rating
  • Negative Sentiment: BMO Capital Markets cut its price target from $18 to $15 and Canaccord Genuity reduced its target from $17 to $14; both firms now carry middle-ground ratings. UBS also lowered its target, adding to investor concerns about UiPath’s near-term upside. Why UiPath stock is down today
  • Negative Sentiment: The stock’s decline was compounded by rising Treasury yields and a broader software-sector selloff. Although annual recurring revenue reached $1.938 billion, investors appeared focused on valuation pressure and the shares’ persistent monthly downtrend. UiPath stock falls as ARR reaches $1.938 billion

Insiders Place Their Bets

In other news, CEO Daniel Dines sold 1,402,347 shares of the stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total value of $22,535,716.29. Following the completion of the transaction, the chief executive officer directly owned 26,491,238 shares in the company, valued at $425,714,194.66. This trade represents a 5.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Raghavendra Malpani sold 40,464 shares of the firm’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $14.00, for a total transaction of $566,496.00. Following the transaction, the insider owned 1,582,213 shares in the company, valued at $22,150,982. This represents a 2.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 1,560,150 shares of company stock worth $24,727,357. 22.44% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UiPath

A number of institutional investors have recently added to or reduced their stakes in PATH. BlackRock Inc. increased its position in shares of UiPath by 7.2% during the 2nd quarter. BlackRock Inc. now owns 46,153,124 shares of the company’s stock valued at $501,684,000 after purchasing an additional 3,097,822 shares during the period. Redwood Investment Management LLC acquired a new stake in shares of UiPath in the second quarter valued at $1,183,000. First Trust Advisors LP lifted its holdings in shares of UiPath by 48.7% in the first quarter. First Trust Advisors LP now owns 1,624,148 shares of the company’s stock valued at $18,028,000 after buying an additional 532,157 shares during the period. Hsbc Holdings PLC boosted its stake in UiPath by 269.1% during the second quarter. Hsbc Holdings PLC now owns 739,993 shares of the company’s stock valued at $7,967,000 after buying an additional 539,528 shares in the last quarter. Finally, State of Michigan Retirement System bought a new position in UiPath during the first quarter valued at about $1,143,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

UiPath Trading Down 1.0%

Shares of NYSE:PATH opened at $12.47 on Friday. The firm’s 50 day moving average is $14.53 and its two-hundred day moving average is $12.23. The firm has a market capitalization of $6.50 billion, a P/E ratio of 18.62, a PEG ratio of 1.18 and a beta of 1.02. UiPath has a 52 week low of $9.20 and a 52 week high of $19.84.

UiPath (NYSE:PATH – Get Free Report) last issued its quarterly earnings data on Thursday, September 3rd. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. UiPath had a return on equity of 9.70% and a net margin of 21.03%.The business had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. During the same period in the previous year, the firm posted $0.15 earnings per share. The business’s revenue was up 13.3% on a year-over-year basis. Analysts predict that UiPath will post 0.49 EPS for the current year.

About UiPath

(Get Free Report)

UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.

See Also

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.